12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Quidel Molecular RSV + hMPV regulatory update

Quidel said it received CE Mark approval for Quidel Molecular RSV + hMPV to detect...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >